Another study demonstrated that the expression of Parkin is down-regulated in the liver during NAFLD; on the contrary, reversing Parkin-related mitophagy could protect mitochondria and hepatocytes from HFD-induced oxidative injury [21]. The gene discussed is PRKN; the disease is metabolic dysfunction-associated steatotic liver disease.